.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Fuji
Julphar
UBS
Chubb
Deloitte
Boehringer Ingelheim
Argus Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

Triamcinolone diacetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone diacetate and what is the scope of triamcinolone diacetate patent protection?

Triamcinolone diacetate
is the generic ingredient in three branded drugs marketed by Sandoz, Delcor Asset Corp, Akorn, Watson Labs, and Astellas, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for triamcinolone diacetate.

Summary for Generic Name: triamcinolone diacetate

Tradenames:3
Patents:1
Applicants:5
NDAs:8
Drug Master File Entries: see list50
Bulk Api Vendors: see list33
Clinical Trials: see list230
Patent Applications: see list1,667
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:triamcinolone diacetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
ARISTOCORT
triamcinolone diacetate
INJECTABLE;INJECTION011685-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRIAMCINOLONE DIACETATE
triamcinolone diacetate
INJECTABLE;INJECTION085529-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Akorn
TRIAMCINOLONE DIACETATE
triamcinolone diacetate
INJECTABLE;INJECTION085122-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Astellas
ARISTOCORT
triamcinolone diacetate
SYRUP;ORAL011960-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone diacetate
SYRUP;ORAL012515-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
UBS
Cipla
Cerilliant
Accenture
McKesson
US Department of Justice
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot